UnitedHealth Is the Worst Dow Jones Stock Thursday. Here's Why
UnitedHealth is putting pressure on the 30-stock index Thursday after the insurance giant reported a rare revenue miss. This is what you need to know.


UnitedHealth Group (UNH) is the worst Dow Jones stock Thursday, putting pressure on the price-weighted index, after the health insurance company reported mixed results for its fourth quarter.
In the three months ending December 31, UnitedHealth's revenue increased 6.8% year over year to $100.8 billion, thanks in part to a 4.4% rise in premiums to $76.5 billion. Its earnings per share (EPS) were up 10.6% from the year-ago period to $6.81.
"The people of UnitedHealth Group remain focused on making high-quality, affordable healthcare more available to more people while making the health system easier to navigate for patients and providers, positioning us well for growth in 2025," said UnitedHealth CEO Andrew Witty in a statement.

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
While the company's earnings topped the $6.72 per share that Wall Street was anticipating, UNH's revenue fell short of the $101.8 billion analysts called for, according to CNBC. This marks the first top-line miss for UnitedHealth since Q2 2020. Revenue from premiums also came in below expectations of $78.1 billion.
Additionally, UnitedHealth reaffirmed the 2025 outlook it provided last month, which calls for revenue in the range of $450 billion to $455 billion and earnings per share between $29.50 to $30.
Is UnitedHealth stock a buy, sell or hold?
UnitedHealth has underperformed the broad market over the past 12 months, up 6% on a total return basis (price change plus dividends) vs the S&P 500's 26% gain. But Wall Street remains overwhelmingly bullish on the blue chip stock.
According to S&P Global Market Intelligence, the average analyst target price for UNH stock is $639.16, representing implied upside of more than 20% to current levels. Additionally, the consensus recommendation is a Strong Buy.
Financial services firm Oppenheimer has an Outperform rating (equivalent to a Buy) on UNH stock with a $640 price target.
"We believe UNH is well positioned by virtue of its diversification, strong track record, elite management team, and exposure to certain higher growth businesses," wrote Oppenheimer analyst Michael Wiederhorn in a December 5 note.
He adds that UnitedHealth's Optum business "is a nice complement to its core managed care operations and continues to account for a large share of earnings" and its "vertical integration strategy strengthens the company's competitive positioning across many areas of the healthcare landscape."
Related Content
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Joey Solitro is a freelance financial journalist at Kiplinger with more than a decade of experience. A longtime equity analyst, Joey has covered a range of industries for media outlets including The Motley Fool, Seeking Alpha, Market Realist, and TipRanks. Joey holds a bachelor's degree in business administration.
-
Taxpayer Revolt? Why More People Are Avoiding Filing Taxes This Year
Tax Season It may be tempting to skip filing due to the overwhelmed IRS, but doing so could have financial and legal consequences.
By Kelley R. Taylor Published
-
Winning Strategies for Financial Advisers as Clients' Lives Evolve
How can the wealth management industry help make life transitions easier for the adviser and the client?
By David Conti, CPRC Published
-
Winning Strategies for Financial Advisers as Clients' Lives Evolve
How can the wealth management industry help make life transitions easier for the adviser and the client?
By David Conti, CPRC Published
-
How Advisers Can Establish Relationships With HNW Prospects
These strategies can help to build influence with high-net-worth individuals, who are often looking to an adviser for insight rather than solutions.
By Jeremy Green, CFP®, CTFA, CLU®, CEBS®, AEP®, EA, MSFS Published
-
When Your Car Is Fixed, But You've Still Got the Problem
This reader's experience with trying to get squealing brakes fixed under an extended warranty mirrors what others are experiencing these days.
By H. Dennis Beaver, Esq. Published
-
Stock Market Today: Dow Rises 854 Points From Its Intraday Low
If there's one thing markets hate, it's uncertainty. But uncertainty is all they're getting these days.
By David Dittman Published
-
Seven Questions to Ask When Evaluating Personal Loan Options
Taking out a personal loan too hastily could lock you into unfavorable terms with an untrustworthy lender. Ask these questions before signing anything.
By David Kimball Published
-
How Much Does Being Rich Matter in Retirement?
After a certain point, having more money in retirement won't make you any happier, new research shows. Instead, physical health, a sense of purpose, and a minimal amount of non-mortgage debt are more relevant.
By Christy Bieber Published
-
The Three Biggest Fears Keeping Retirees Up at Night
Here are the steps you can take to put those fears to rest and retire with confidence so you can relax and enjoy the life you've planned.
By Pam Krueger Published
-
What Can a Donor-Advised Fund Do for You? (A Lot)
DAFs and private foundations go about helping charities (and those who donate) in different ways. Each comes with its own benefits and restrictions to navigate.
By Julia Chu Published